Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions …

Background: A growing body of evidence has linked mental health outcomes to the gut
microbiome. This has led to the investigation of the GI tract as a target for novel treatments …

Background Disturbance in the equilibrium of the gut microbiota has been involved in the
pathophysiology of depression. Probiotics have the potential to healthfully modulate the gut …

Background: A growing body of research has shown that consumption of probiotics can
improve symptoms associated with mood and anxiety disorders through activity of the gut …

Depression is the major cause of disability globally. Apart from lowered mood and
accompanying symptoms, it leads to cognitive impairment that altogether predicts …

During the past decade, there has been renewed interest in the relationship between brain-
based disorders, the gut microbiota, and the possible beneficial effects of probiotics …

Background Probiotics are suggested to improve depressive symptoms via the microbiota-
gut-brain axis. We have recently shown a beneficial clinical effect of probiotic …

Background The potential antidepressant properties of probiotics have been suggested, but
their influence on the emotional processes that may underlie this effect is unclear. Methods …

Background: Recent insights into the role of the human microbiota in cognitive and affective
functioning have led to the hypothesis that probiotic supplementation may act as an adjuvant …